Overview
When ValueAct Capital Partners sees untapped value, it acts. The firm, known for its activist slant, buys large stakes in undervalued companies and works with management to boost performance. ValueAct leaders also often sit on the boards of the companies in its portfolio. Founded in 2000, ValueAct manages some $3.5 billion on behalf of institutional and wealthy individual investors. It has offices in Boston and San Francisco. ValueAct focuses
...
Read More on making investments in the software, pharmaceutical, media and communications, and medical technology sectors. The firm's current portfolio includes stakes in Thomson Reuters, MDS Inc., VeriSign, Misys, and Immucor.
Read Less
Read More on making investments in the software, pharmaceutical, media and communications, and medical technology sectors. The firm's current portfolio includes stakes in Thomson Reuters, MDS Inc., VeriSign, Misys, and Immucor.
Read Less
Other Financial Investment Activities
,
Securities, Commodity Contracts, and Other Financial Investments and Related Activities
,
Finance and Insurance
,
Investors, nec
Activities Related to Credit Intermediation
,
Agencies, Brokerages, and Other Insurance Related Activities
,
Depository Credit Intermediation
,
Insurance Carriers
,
Insurance and Employee Benefit Funds
,
Monetary Authorities-Central Bank
,
Nondepository Credit Intermediation
,
Other Investment Pools and Funds
View more , Securities and Commodity Contracts Intermediation and Brokerage Securities and Commodity Exchanges
View fewer
View more , Securities and Commodity Contracts Intermediation and Brokerage Securities and Commodity Exchanges
View fewer
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Data
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.